J&J Beats on Tremfya Strength as Mideast Conflict Hits Devices
Johnson and Johnson posted third-quarter adjusted earnings of $2.59 a share on revenue of $25.4 billion, clearing Wall Street targets of $2.54 and $25
Stelara
Every Fin-node story mentioning Stelara — 1 story, newest first.
Stelara · 1 story